Cargando…

EMT and Treatment Resistance in Pancreatic Cancer

Pancreatic cancer (PC) is the third leading cause of adult cancer mortality in the United States. The poor prognosis for patients with PC is mainly due to its aggressive course, the limited efficacy of active systemic treatments, and a metastatic behavior, demonstrated throughout the evolution of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaianigo, Nicola, Melisi, Davide, Carbone, Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615337/ https://www.ncbi.nlm.nih.gov/pubmed/28895920 http://dx.doi.org/10.3390/cancers9090122

Ejemplares similares

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013)

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
por: Carbone, Carmine, et al.
Publicado: (2014)

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
por: Cascetta, Priscilla, et al.
Publicado: (2018)

Permissive State of EMT: The Role of Immune Cell Compartment
por: Fedele, Vita, et al.
Publicado: (2020)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
por: Carbone, Carmine, et al.
Publicado: (2018)

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
por: Zhou, Pingting, et al.
Publicado: (2017)

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling
por: Carbone, C, et al.
Publicado: (2018)

HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies
por: Contarelli, Serena, et al.
Publicado: (2020)

microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
por: Funamizu, Naotake, et al.
Publicado: (2023)

EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells
por: Rodriguez-Aznar, Eva, et al.
Publicado: (2019)

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
por: Hindriksen, Sanne, et al.
Publicado: (2012)

Role of EMT in Metastasis and Therapy Resistance
por: Smith, Bethany N., et al.
Publicado: (2016)

Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
por: Teeuwssen, Miriam, et al.
Publicado: (2019)

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
por: Pietrobono, Silvia, et al.
Publicado: (2021)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

A circulating T(H)2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
por: Piro, Geny, et al.
Publicado: (2017)

From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Cancer drug resistance induced by EMT: novel therapeutic strategies
por: De Las Rivas, Javier, et al.
Publicado: (2021)

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
por: Du, Bowen, et al.
Publicado: (2016)

EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
por: Pan, Guangtao, et al.
Publicado: (2021)

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
por: Ren, Yuqing, et al.
Publicado: (2023)

Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cells
por: Zhao, Hengqiang, et al.
Publicado: (2017)

EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
por: Tang, Yaqi, et al.
Publicado: (2020)

Tumor Budding: The Name is EMT. Partial EMT.
por: Grigore, Alexandru Dan, et al.
Publicado: (2016)

EMT in immuno-resistance
por: Terry, Stéphane, et al.
Publicado: (2015)

EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer
por: Zheng, Xiaofeng, et al.
Publicado: (2015)

E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
por: Sommariva, Michele, et al.
Publicado: (2020)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
por: Fiori, Micol Eleonora, et al.
Publicado: (2019)

Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization
por: Yan, Tao, et al.
Publicado: (2017)

Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015)

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017)

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms
por: Venugopal, Abhirami, et al.
Publicado: (2022)

Tissue transglutaminase: a new target to reverse cancer drug resistance
por: Budillon, Alfredo, et al.
Publicado: (2011)

Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo
por: Lupo, Francesca, et al.
Publicado: (2020)

Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
por: Recouvreux, Maria Victoria, et al.
Publicado: (2020)

S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
por: Low, Ronnie Ren Jie, et al.
Publicado: (2023)

Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
por: Li, Dandan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tpu3br7k30k0sn4k0uedhkopt0